Who is sponsoring NCT03969797?

NCT03969797 is sponsored by RadianQbio.

What drugs are being tested in NCT03969797?

Interventions in NCT03969797: RADIAQBIO Heart Guardian HR-501.

What condition does NCT03969797 study?

NCT03969797 studies Cardiac Arrest, Sudden.

Is NCT03969797 still recruiting?

NCT03969797 is currently completed. Last updated 31 May 2019.

Last reviewed 2019-05-31 · How we verify

NCT03969797

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

AED Log Analysis of 19 Cases in Out-of-hospital Environment

Completed Last updated 31 May 2019

What this trial tests

trial testing RADIAQBIO Heart Guardian HR-501 in Cardiac Arrest, Sudden in 19 participants. Completed in 15 January 2019.

Timeline

25 March 2016

Primary endpoint
8 October 2018

15 January 2019

Quick facts

Lead sponsor	RadianQbio
Status	Completed
Study type	OBSERVATIONAL
Enrollment	19
Start date	25 March 2016
Primary completion	8 October 2018
Estimated completion	15 January 2019
Sites	1 location across South Korea

Drugs / interventions tested

RADIAQBIO Heart Guardian HR-501

Conditions studied

Cardiac Arrest, Sudden — all drugs for Cardiac Arrest, Sudden →

Sponsor

RadianQbio

Who can join

1 and older, any sex, with Cardiac Arrest, Sudden. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study performed to demonstrate a reasonable assurance of safety and effectiveness of the Heart Guardian HR-501 when used in an out-of-hospital environment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cardiac Arrest, Sudden

Currently open trials in the same condition.

NCT03894059 — An Educational Program to Improve Cardiac Arrest Diagnostic Accuracy of Ambulance Telecommunicators · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03969797 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by RadianQbio
Last refreshed: 31 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03969797.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing